|
1
|
Malek SN: The biology and clinical
significance of acquired genomic copy number aberrations and
recurrent gene mutations in chronic lymphocytic leukemia. Oncogene.
32:2805–2817. 2013. View Article : Google Scholar :
|
|
2
|
Zhu DX, Zhu W, Fang C, Fan L, Zou ZJ, Wang
YH, Liu P, Hong M, Miao KR, Liu P, et al: miR-181a/b significantly
enhances drug sensitivity in chronic lymphocytic leukemia cells via
targeting multiple anti-apoptosis genes. Carcinogenesis.
33:1294–1301. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wójtowicz M and Wołowiec W: Dysregulation
of apoptosis and proliferation in CLL cells. Chronic Lymphocytic
Leukemia. Intech; Rijeka: pp. 37–62. 2012, View Article : Google Scholar
|
|
4
|
Bianchi S, Dighiero G and Pritsch O:
Selected topics in chronic lymphocytic leukemia pathogenesis.
Chronic Lymphocytic Leukemia. Intech; Rijeka: pp. 3–18. 2012,
http://cdn.intechopen.com/pdfs-wm/27981.pdf.
|
|
5
|
Rozovski U, Hazan-Halevy I, Keating MJ and
Estrov Z: Personalized medicine in CLL: Current status and future
perspectives. Cancer Lett. 352:4–14. 2014. View Article : Google Scholar
|
|
6
|
Antosz H, Paterski A, Marzec-Kotarska B,
Sajewicz J and Dmoszyńska A: Alterations in TP53, cyclin D2, c-Myc,
p21WAF1/CIP1 and p27KIP1 expression associated with
progression in B-CLL. Folia Histochem Cytobiol. 48:534–541. 2010.
View Article : Google Scholar
|
|
7
|
Marschitz I, Tinhofer I, Hittmair A, Egle
A, Kos M and Greil R: Analysis of Bcl-2 protein expression in
chronic lymphocytic leukemia. A comparison of three
semiquantitation techniques. Am J Clin Pathol. 113:219–229. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Podhorecka M, Halicka D, Klimek P, Kowal
M, Chocholska S and Dmoszynska A: Resveratrol increases rate of
apoptosis caused by purine analogues in malignant lymphocytes of
chronic lymphocytic leukemia. Ann Hematol. 90:173–183. 2011.
View Article : Google Scholar :
|
|
9
|
Salakou S, Kardamakis D, Tsamandas AC,
Zolota V, Apostolakis E, Tzelepi V, Papathanasopoulos P, Bonikos
DS, Papapetropoulos T, Petsas T, et al: Increased Bax/Bcl-2 ratio
up-regulates caspase-3 and increases apoptosis in the thymus of
patients with myasthenia gravis. In Vivo. 21:123–132.
2007.PubMed/NCBI
|
|
10
|
Fu NY, Sukumaran SK and Yu VC: Inhibition
of ubiquitin-mediated degradation of MOAP-1 by apoptotic stimuli
promotes Bax function in mitochondria. Proc Natl Acad Sci USA.
104:10051–10056. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Woyach JA and Johnson AJ: Targeted
therapies in CLL: Mechanisms of resistance and strategies for
management. Blood. 126:471–477. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Huang Y, Wu JZ, Li JY and Xu W: Know the
enemy as well as the weapons in hand: The aberrant death pathways
and therapeutic agents in chronic lymphocytic leukemia. Am J Cancer
Res. 5:2361–2375. 2015.PubMed/NCBI
|
|
13
|
Wang YC and Huang TL: Screening of
anti-Helicobacter pylori herbs deriving from Taiwanese folk
medicinal plants. FEMS Immunol Med Microbiol. 43:295–300. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang YC and Huang TL: Anti-Helicobacter
pylori activity of Plumbago zeylanica L. FEMS Immunol Med
Microbiol. 43:407–412. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Eldhose B, Gunawan M, Rahman M, Latha MS
and Notario V: Plumbagin reduces human colon cancer cell survival
by inducing cell cycle arrest and mitochondria-mediated apoptosis.
Int J Oncol. 45:1913–1920. 2014.PubMed/NCBI
|
|
16
|
Pekarsky Y, Zanesi N and Croce CM:
Molecular basis of CLL. Semin Cancer Biol. 20:370–376. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hanada M, Delia D, Aiello A, Stadtmauer E
and Reed JC: bcl-2 gene hypomethylation and high-level expression
in B-cell chronic lymphocytic leukemia. Blood. 82:1820–1828.
1993.PubMed/NCBI
|
|
18
|
Liu FT, Giustiniani J, Farren T, Jia L,
Bensussan A, Gribben JG and Agrawal SG: CD160 signaling mediates
PI3K-dependent survival and growth signals in chronic lymphocytic
leukemia. Blood. 115:3079–3088. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Furman RR, Asgary Z, Mascarenhas JO, Liou
HC and Schattner EJ: Modulation of NF-kappa B activity and
apoptosis in chronic lymphocytic leukemia B cells. J Immunol.
164:2200–2206. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yan CH, Li F and Ma YC: Plumbagin shows
anticancer activity in human osteosarcoma (MG-63) cells via the
inhibition of S-Phase checkpoints and down-regulation of c-myc. Int
J Clin Exp Med. 8:14432–14439. 2015.PubMed/NCBI
|
|
21
|
Qiu JX, He YQ, Wang Y, Xu RL, Qin Y, Shen
X, Zhou SF and Mao ZF: Plumbagin induces the apoptosis of human
tongue carcinoma cells through the mitochondria-mediated pathway.
Med Sci Monit Basic Res. 19:228–236. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu X, Cai W, Niu M, Chong Y, Liu H, Hu W,
Wang D, Gao S, Shi Q, Hu J, et al: Plumbagin induces growth
inhibition of human glioma cells by downregulating the expression
and activity of FOXM1. J Neurooncol. 121:469–477. 2015. View Article : Google Scholar
|
|
23
|
Wang J, Guo W, Zhou H, Luo N, Nie C, Zhao
X, Yuan Z, Liu X and Wei Y: Mitochondrial p53 phosphorylation
induces Bak-mediated and caspase-independent cell death.
Oncotarget. 6:17192–17205. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pan ST, Qin Y, Zhou ZW, He ZX, Zhang X,
Yang T, Yang YX, Wang D, Qiu JX and Zhou SF: Plumbagin induces
G2/M arrest, apoptosis, and autophagy via p38 MAPK- and
PI3K/Akt/mTOR-mediated pathways in human tongue squamous cell
carcinoma cells. Drug Des Devel Ther. 9:1601–1626. 2015.
|
|
25
|
Hafeez BB, Zhong W, Fischer JW, Mustafa A,
Shi X, Meske L, Hong H, Cai W, Havighurst T, Kim K, et al:
Plumbagin, a medicinal plant (Plumbago zeylanica)-derived
1,4-naphthoquinone, inhibits growth and metastasis of human
prostate cancer PC-3M-luciferase cells in an orthotopic xenograft
mouse model. Mol Oncol. 7:428–439. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dyer MJ, Zani VJ, Lu WZ, O'Byrne A, Mould
S, Chapman R, Heward JM, Kayano H, Jadayel D, Matutes E, et al:
BCL2 translocations in leukemias of mature B cells. Blood.
83:3682–3688. 1994.PubMed/NCBI
|
|
27
|
Vrhovac R, Delmer A, Tang R, Marie JP,
Zittoun R and Ajchenbaum-Cymbalista F: Prognostic significance of
the cell cycle inhibitor p27Kip1 in chronic B-cell
lymphocytic leukemia. Blood. 91:4694–4700. 1998.PubMed/NCBI
|
